Ellogon AI Company
AI-powered Computational Pathology for Immunotherapy
Total Funding:
653661
Headquarters:
Amsterdam, Noord-Holland, The Netherlands
Funding Status:
Seed
Employee Number:
1-10
Last Funding Type:
Convertible Note
Last Funding Date:
2021-08-24
Investors Number:
1
Founded Date:
2019-05-01
Industry:
Biomarkers